Terumo (OTCMKTS:TRUMY) Shares Gap Up – Here’s What Happened

Terumo Corp. (OTCMKTS:TRUMY – Get Free Report)’s share price gapped up prior to trading on Monday. The stock had previously closed at $14.6785, but opened at $15.2450. Terumo shares last traded at $15.32, with a volume of 7,606 shares.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. Nomura raised shares of Terumo from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 30th. Zacks Research upgraded shares of Terumo from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 13th. Two research analysts have rated the stock with a Strong Buy rating. According to MarketBeat.com, the company currently has an average rating of “Strong Buy”.

Read Our Latest Stock Report on TRUMY

Terumo Price Performance

The company has a current ratio of 2.19, a quick ratio of 1.37 and a debt-to-equity ratio of 0.13. The stock has a market cap of $22.60 billion, a price-to-earnings ratio of 31.92 and a beta of 0.82. The stock has a 50-day moving average price of $14.80 and a two-hundred day moving average price of $14.09.

Terumo (OTCMKTS:TRUMY – Get Free Report) last announced its earnings results on Thursday, November 12th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.01) by ($0.06). Terumo had a net margin of 9.31% and a return on equity of 7.03%. The business had revenue of $1.96 billion for the quarter, compared to analyst estimates of $1.94 billion. As a group, equities research analysts forecast that Terumo Corp. will post 0.86 EPS for the current year.

About Terumo

(Get Free Report)

Terumo Corporation is a Japan-based medical technology company that develops and manufactures products for hospitals, clinics and other healthcare providers. Founded in 1921, the company began by producing clinical thermometers and has since expanded into a broad range of medical devices and services. Terumo’s businesses include cardiovascular and vascular products, such as catheter-based devices and systems used in the treatment of heart and vascular conditions; medical care products, including infusion and injection devices; and blood and cell technologies used to collect, process and manage blood and cellular therapies.

Recommended Stories

Receive News & Ratings for Terumo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Terumo and related companies with MarketBeat.com's FREE daily email newsletter.